BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 30803555)

  • 1. A diagnosis of discernment: Identifying a novel ATRX mutation in myelodysplastic syndrome with acquired α-thalassemia.
    Wykretowicz J; Song Y; McKnight B; Choi SW; Magenau J; Takiar R; Tomb PE; Ginsburg D; Bixby D; Khoriaty R
    Cancer Genet; 2019 Feb; 231-232():36-40. PubMed ID: 30803555
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A new ATRX mutation in a patient with acquired α-thalassemia myelodysplastic syndrome.
    Herbaux C; Badens C; Guidez S; Lacoste C; Maboudou P; Rose C
    Hemoglobin; 2012; 36(6):581-5. PubMed ID: 23092150
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A novel ATRX splice variant causing acquired HbH disease in myelodysplastic syndrome with excess blasts-1.
    Mallik N; Singh N; Jamwal M; Chhabra S; Hira JK; Malhotra P; Das R; Sharma P
    Cancer Genet; 2022 Jan; 260-261():53-56. PubMed ID: 34330696
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel 5' ATRX mutation with splicing consequences in acquired alpha thalassemia-myelodysplastic syndrome.
    Nelson ME; Thurmes PJ; Hoyer JD; Steensma DP
    Haematologica; 2005 Nov; 90(11):1463-70. PubMed ID: 16266892
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel ATRX variant with splicing consequences in myelodysplastic syndrome with acquired alpha thalassaemia.
    Nguyen PC; Tiong IS; Westerman DA; Blombery P
    Br J Haematol; 2023 Jan; 200(1):e13-e16. PubMed ID: 36278851
    [No Abstract]   [Full Text] [Related]  

  • 6. [Acquired alpha-thalassemia in an 86-year-old patient with myelodysplastic syndrome].
    Cortese D; Martinez C; Dindoyal A; Alamome I; Dragan R; Chapiro J; Blaison G; Hinschberger O
    Rev Med Interne; 2023 Feb; 44(2):89-91. PubMed ID: 36646614
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acquired somatic ATRX mutations in myelodysplastic syndrome associated with alpha thalassemia (ATMDS) convey a more severe hematologic phenotype than germline ATRX mutations.
    Steensma DP; Higgs DR; Fisher CA; Gibbons RJ
    Blood; 2004 Mar; 103(6):2019-26. PubMed ID: 14592816
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Incidence of ATRX mutations in myelodysplastic syndromes, the value of microcytosis.
    Herbaux C; Duployez N; Badens C; Poret N; Gardin C; Decamp M; Eclache V; Daliphard S; Murati A; Cony-Makhoul P; Cheze S; Beve B; Lacoste C; Prebet T; Hunault-Berger M; Maloisel F; Renneville A; Figeac M; Stamatoullas-Bastard A; Bastard C; Fenaux P; Preudhomme C; Rose C;
    Am J Hematol; 2015 Aug; 90(8):737-8. PubMed ID: 26017030
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A novel mutation in the last exon of ATRX in a patient with alpha-thalassemia myelodysplastic syndrome.
    Costa DB; Fisher CA; Miller KB; Pihan GA; Steensma DP; Gibbons RJ; Higgs DR
    Eur J Haematol; 2006 May; 76(5):432-5, 453. PubMed ID: 16480427
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Deletion of the alpha-globin gene cluster as a cause of acquired alpha-thalassemia in myelodysplastic syndrome.
    Steensma DP; Viprakasit V; Hendrick A; Goff DK; Leach J; Gibbons RJ; Higgs DR
    Blood; 2004 Feb; 103(4):1518-20. PubMed ID: 14576055
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of X-inactivation in the gender bias of patients with acquired alpha-thalassaemia and myelodysplastic syndrome (ATMDS).
    Haas PS; Roy NB; Gibbons RJ; Deville MA; Fisher C; Schwabe M; Bissé E; van Dorsselaer A; Higgs DR; Lübbert M
    Br J Haematol; 2009 Feb; 144(4):538-45. PubMed ID: 19055664
    [TBL] [Abstract][Full Text] [Related]  

  • 12. De novo and acquired forms of alpha thalassemia.
    Forget BG
    Curr Hematol Rep; 2006 Mar; 5(1):11-4. PubMed ID: 16537041
    [TBL] [Abstract][Full Text] [Related]  

  • 13. α-Thalassemia, mental retardation, and myelodysplastic syndrome.
    Gibbons RJ
    Cold Spring Harb Perspect Med; 2012 Oct; 2(10):. PubMed ID: 23028133
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Acquired alpha-thalassemia as early sign for myelodysplastic syndrome (refractory anaemia) with secondary haemochromatosis].
    Perrin J; Perrot A; Chenot V; Lesesve JF; Guerci A; Marchand-Arvier M; Vigneron C; Lecompte T
    Ann Biol Clin (Paris); 2007; 65(4):405-9. PubMed ID: 17627922
    [TBL] [Abstract][Full Text] [Related]  

  • 15. X-linked alpha thalassaemia/mental retardation syndrome: a case with gonadal dysgenesis, caused by a novel mutation in ATRX gene.
    Jezela-Stanek A; Fisher C; Szarras-Czapnik M; Olczak-Kowalczyk D; Gibbons RJ; Słowikowska-Hilczer J; Krajewska-Walasek M
    Clin Dysmorphol; 2009 Jul; 18(3):168-171. PubMed ID: 19444090
    [No Abstract]   [Full Text] [Related]  

  • 16. Abnormal hemoglobin H band in myelodysplastic syndromes (MDS): A case report.
    Liu C; Zou C; Zou S; Wang Q; Xiao D; Zhang L
    Transfus Clin Biol; 2021 May; 28(2):206-210. PubMed ID: 33221503
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acquired alpha-thalassemia in association with myelodysplastic syndrome and other hematologic malignancies.
    Steensma DP; Gibbons RJ; Higgs DR
    Blood; 2005 Jan; 105(2):443-52. PubMed ID: 15358626
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of acquired somatic mutations in the gene encoding chromatin-remodeling factor ATRX in the alpha-thalassemia myelodysplasia syndrome (ATMDS).
    Gibbons RJ; Pellagatti A; Garrick D; Wood WG; Malik N; Ayyub H; Langford C; Boultwood J; Wainscoat JS; Higgs DR
    Nat Genet; 2003 Aug; 34(4):446-9. PubMed ID: 12858175
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of epigenetic signature associated with alpha thalassemia/mental retardation X-linked syndrome.
    Schenkel LC; Kernohan KD; McBride A; Reina D; Hodge A; Ainsworth PJ; Rodenhiser DI; Pare G; Bérubé NG; Skinner C; Boycott KM; Schwartz C; Sadikovic B
    Epigenetics Chromatin; 2017; 10():10. PubMed ID: 28293299
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Does ATRX germline variation predispose to osteosarcoma? Three additional cases of osteosarcoma in two ATR-X syndrome patients.
    Masliah-Planchon J; Lévy D; Héron D; Giuliano F; Badens C; Fréneaux P; Galmiche L; Guinebretierre JM; Cellier C; Waterfall JJ; Aït-Raïs K; Pierron G; Glorion C; Desguerre I; Soler C; Deville A; Delattre O; Michon J; Bourdeaut F
    Eur J Hum Genet; 2018 Aug; 26(8):1217-1221. PubMed ID: 29706636
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.